CD47 and cancer: In another study that investigated the role of intratumor microbiota in CD47-based cancer immunotherapy, Shi et al. found that colonic Bifidobacterium accumulates in tumor sites and facilitates local anti-CD47 treatment via the STING pathway (Shi et al., 2020).